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PATTERNS & PHENOTYPES
Cloning and Expression Pattern of Chicken
Ror2 and Functional Characterization of
Truncating Mutations in Brachydactyly Type B
and Robinow Syndrome
Sigmar Stricker,1,2* Nicole Verhey van Wijk,1,2 Florian Witte,1,2 Norbert Brieske,1 Kathrin Seidel,1
and Stefan Mundlos1,2
Ror2 is a receptor tyrosine kinase mutated in the human syndromes Brachydactyly type B (BDB) and
recessive Robinow syndrome (RS). In this study, we used the chick as a model to investigate the role of Ror2
in skeletogenesis and to elucidate the functional consequences of Ror2 mutations. For this purpose, we
cloned chicken Ror2 and analyzed its expression pattern at various embryonic stages by in situ
hybridization and immunolabeling. We document expression of cRor2 in several organs, including
mesonephros, heart, nervous system, intestine and cartilage. The high conservation of expression when
compared with the mouse underlines the validity of the chick as a model system. Using replication-
competent retroviral vector–mediated overexpression, we analyzed the functional consequences of
truncating BDB and RS mutations in the developing chick limb. Overexpression of Ror2 mutants led to a
disturbance of growth plate architecture and a severe block of chondrocyte differentiation, demonstrating
the functional importance of Ror2 in skeletogenesis. Developmental Dynamics 235:3456–3465, 2006.
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INTRODUCTION
Mammalian Ror2 and the closely re-
lated paralog Ror1 belong to a small
family of receptor tyrosine kinases
(RTKs) that have been characterized
by their homology to MuSK and Trk-
RTKs (Masiakowski and Carroll,
1992; Valenzuela et al., 1995). Ror2
possesses an intracellular tyrosine ki-
nase domain and a C-terminal pro-
line–serine–threonine—rich (PST) do-
main. In its extracellular part, Ror2
has an immunoglobulin-like domain,
a cysteine-rich domain showing high
homology to frizzled receptors (Sal-
danha et al., 1998) and a kringle do-
main. Ror2 orthologs have been found
in Drosophila melanogaster (Wilson et
al., 1993; Oishi et al., 1997), Caeno-
rhabditis elegans (Forrester et al.,
1999), Aplysia californica (McKay et
al., 2001), Xenopus laevis (Hikasa et
al., 2002), Mus musculus (Oishi et al.,
1999), and Rattus norvegicus (Masia-
kowski and Carroll, 1992; Katoh and
Katoh, 2005).
Expression of Ror2 has been exten-
sively studied in the mouse. In the
early embryo, Ror2 is expressed in
neural crest cells, neural tube, and
primitive streak. Later, Ror2 is ex-
pressed in limb buds, mandibular
arches, the otic capsule, and the telen-
cephalon. After organogenesis, Ror2
shows a widespread expression and is
found in the nervous system, in devel-
oping heart and lung, in the urogenital
system and also in cartilage (Al-Shawi
et al., 2001; Matsuda et al., 2001).
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Ror2 is an orphan receptor, and lit-
tle is known about the pathway(s) it
activates. There is accumulating evi-
dence that Ror2 is implicated in Wnt
signaling. In Xenopus, XRor2 is in-
volved in the regulation of convergent
extension, where it acts in synergy
with the noncanonical XWnt11/silber-
blick (Hikasa et al., 2002). In mouse,
Ror2 interacts with Wnt5a, thereby
signaling by means of the noncanoni-
cal JNK-pathway (Oishi et al., 2003;
Mikels and Nusse, 2006). Addition-
ally, Ror2 has been implicated in
Gdf5/BmpR1b signaling (Sammar et
al., 2004).
The function of Ror2 has been elu-
cidated by the ﬁnding that distinct
truncating mutations in human ROR2
can cause Brachydactyly type B (BDB,
MIM 113000; Oldridge et al., 2000;
Schwabe et al., 2000). BDB is a hu-
man limb malformation syndrome
characterized by hypoplasia and/or
aplasia of distal phalanges. Further-
more, mutations in ROR2 are caus-
ative for a very distinct syndrome, au-
tosomal recessive Robinow syndrome
(RS, MIM268310; Afzal et al., 2000;
van Bokhoven et al., 2000). RS is char-
acterized by short stature, mesomelic
limb shortening, hemivertebrae, geni-
tal hypoplasia, and characteristic fa-
cial features (Patton and Afzal, 2002).
Further insights into the functions
of Ror2 came from loss-of-function
studies in the mouse. Homozygous de-
ﬁciency of Ror2 results in perinatal
death with severe cyanosis. Overall,
the Ror2-null embryos show multiple
features overlapping with human RS
(Schwabe et al., 2004). Concordantly
it has been suggested that RS muta-
tions result in loss of function,
whereas BDB mutations act as domi-
nant-negative proteins. Recently, it
has been shown that RS mutations in
the extracellular part of ROR2 lead to
retention of the protein in the endo-
plasmic reticulum, thus leading to a
loss of function (Chen et al., 2005).
Ror2-null mice show a variety of
skeletal defects, including craniofacial
abnormalities and a shortening of
long bones, especially in the limb ze-
ugopod (Takeuchi et al., 2000). Mice
expressing a truncated Ror2-lacZ fu-
sion protein additionally exhibit loss
of medial phalanges (DeChiara et al.,
2000). In cartilage, Ror2 is expressed
in cartilaginous condensations and
throughout the growth plate. Addi-
tional expression is seen in the peri-
chondrium and periosteum (DeChiara
et al., 2000; Schwabe et al., 2004).
Loss of Ror2 leads to a decrease of
chondrocyte differentiation and delay
of ossiﬁcation, thus leading to me-
somelic limb shortening (Schwabe et
al., 2004).
Here we report the cloning and em-
bryonic expression pattern of chicken
Ror2. As the chicken is a widely used
model system in developmental biol-
ogy, we investigated the role of Ror2
in this system by retroviral overex-
pression of truncated forms of cRor2
corresponding to human mutations in
recessive Robinow syndrome and
Brachydactyly type B.
RESULTS AND DISCUSSION
Cloning of Chicken Ror2
Expressed sequence tag (EST) clone
369c3 containing the partial coding
sequence for cRor2 was obtained from
the BBSRC (Boardman et al., 2002).
Using whole chicken embryo day 5
(Hamburger and Hamilton stage [HH]
27) cDNA and genomic DNA, we
cloned the full-length coding sequence
(cds) of cRor2 with a combination
of degenerate reverse transcriptase-
polymerase chain reaction (RT-PCR),
genomic walking, and rapid ampliﬁca-
tion of cDNA ends (RACE). The cRor2
cds consists of 2,805 nucleotides, com-
pared with 2,835 in mouse (Oishi et
al., 1999) and 2,832 in human (Masia-
kowski and Carroll, 1992). The de-
duced amino acid sequence of cRor2
shows a high degree of sequence iden-
tity with mouse and human (83.5%
and 85.8%, respectively). The main
differences are found in the leader
peptide sequence. The extracellular
domains as well as the intracellular
TK and PST domains are highly con-
served (Fig. 1A). In a phylogenetic
tree derived from a multisequence
alignment using all available verte-
brate Ror2 sequences and D. melano-
gaster Ror as an outgroup, cRor2 is
appropriately positioned between X.
laevis Ror2 and the mammalian Ror2
group (Fig. 1B). To preclude inﬂu-
ences of the divergent signal peptide
sequences, an alignment without the
signal peptides was done, which re-
sulted in an identical tree.
Embryonic Expression of
cRor2
The embryonic expression of the Ror2
gene has been extensively studied in
the mouse, but so far no expression
pattern for a nonmammalian verte-
brate Ror2 has been described in de-
tail. To gain an overall insight into the
expression of cRor2, we ﬁrst per-
formed whole-mount in situ hybrid-
ization (WMISH). At HH23–27, we
found expression of cRor2 in the dor-
sal root ganglia (Fig. 2A–D, arrows),
the branchial arches, craniofacial
mesenchyme, and the otic vesicle (ar-
rowheads). Overall, the expression
pattern showed a high overlap with
the expression seen in the mouse at
comparable stages (Matsuda et al.,
2001). Vibratome sections at HH25
demonstrated expression of cRor2 pre-
dominantly in the dorsal–lateral lay-
ers of the dorsal root ganglia (drg, Fig.
2E,F). Section ISH also revealed ex-
pression of cRor2 in dorsal–medial
layers of the drg (Fig. 2G). Strong ex-
pression was also seen in the limb
buds (Fig. 2H,I). In early limb buds,
the expression of cRor2 was detected
all over the limb bud, with stronger
expression in anterior and posterior
areas. At later stages, the expression
of cRor2 in central mesenchyme was
further weakened, while the expres-
sion in the anterior and posterior mar-
gins of the limb stayed intense, a pat-
tern also observed in the mouse
(Matsuda et al., 2001). Vibratome
cross-sections demonstrated strong
expression of cRor2 in mesenchymal
cells directly beneath the ectoderm in
the trunk dermomyotome and in the
limbs but not within the ectoderm
(Fig. 2J).
To gain insight into the expression
of cRor2 during organogenesis, we an-
alyzed the distribution of cRor2
mRNA and protein on embryonic
HH29 (day 6) sections. Speciﬁcity of
signals was conﬁrmed by using a
sense probe for cRor2, which yielded
no signal (not shown). We found ex-
pression of cRor2 mRNA in a variety
of organs (Fig. 3A,B). Strongest ex-
pression was seen in the nervous sys-
tem. Signals were detected in the spi-
nal chord and in the dorsal root
ganglia (Fig. 3G,H). In the head,
cRor2 was expressed in the cerebral
vesicle, the optic lobe, the nasal sac,
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and Meckel’s cartilage (Fig. 3K). Ad-
ditional strong expression was ob-
served in the otic vesicle, the basilar
plate, the acoustic ganglion, and the
cochleovestibular ganglion (Fig.
3K,L). We also detected cRor2 in mus-
cles, such as limb muscles and myo-
cardium (Fig. 3A,C). In the digestive
system, cRor2 showed strong expres-
sion in the gizzard (Fig. 3D) and in the
intestinal loops (Fig. 3I, arrows). Ex-
pression was also seen in the liver (Fig.
3D, arrowhead) and in the lung (Fig. 3J,
arrows). Chicken Ror2 was also de-
tected in the mesonephric tubules (Fig.
3F). Additionally, we found cRor2 ex-
pression in the cartilaginous condensa-
tions of the ribs (Fig. 3E, arrow).
For the immunolabeling on HH29
sections, anti-human ROR2 (R&D
Systems) was used, which gave a clear
signal for the chick Ror2 constructs,
but no cross-reactions on Western
blots made from chicken cell extracts
(see Fig. 5B). The antibody staining
largely conﬁrmed the in situ hybrid-
izations. Chicken Ror2 protein was
Fig. 1. A: Alignment of Gallus gallus (chicken) Ror2 with Homo sapiens (human) and Mus musculus (mouse) Ror2. Conserved amino acids between
the three species are shaded black, and conserved amino acids between only two species are shaded gray. Positions of Brachydactyly type B (BDB)
and Robinow syndrome (RS) mutations used in this study are indicated by an “x” below the alignment. Position where the human 1398insA frameshift
was fused to the chicken sequence (at position 1374) is indicated by an arrow. B: Phylogenetic tree from an alignment of the Ror sequences indicated.
Accession numbers: Mus musculus, BAA75481; Rattus norvegicus, XP_225181; Homo sapiens, Q01974; Canis familiaris, XP_541309; Xenopus laevis,
AB087137; Danio rerio, XP_689681; Drosophila melanogaster, Q24488.
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found in the heart (Fig. 3M), the giz-
zard (Fig. 3N), and the intestine (Fig.
3O). In the mesonephric tubules, the
protein was predominantly localized
to the tubular lumen (Fig. 3P). Ex-
pression of cRor2 was also conﬁrmed
in liver, lung, and dorsal root ganglia
(Fig. 3Q–S).
Overall, the expression pattern of
chicken Ror2 is strikingly similar to
the expression of Ror2 in the mouse
(Al-Shawi et al., 2001; Matsuda et al.,
2001; Schwabe et al., 2004). Thus
there is a high evolutionary conserva-
tion of the embryonic expression pat-
tern of Ror2, indicating functional
conservation. This ﬁnding makes the
chick a valuable model for functional
analysis of Ror2.
Human mutations in ROR2 as well
as the inactivation of Ror2 in the
mouse lead to severe defects in limb
development. As the chicken is an im-
portant developmental model system
and is frequently used for studying
limb development, we analyzed the
expression of cRor2 in this process. As
shown above, in the early limb bud,
cRor2 is expressed in superﬁcial limb
mesenchyme. As the differentiation of
limb mesenchymal cells proceeds, dif-
ferent lineages of tissues arise within
the limb, such as tendons, connective
tissue and cartilage. At HH27, cRor2
could be detected in the early cartilag-
inous condensations of the proximal
skeletal elements of stylopod and ze-
ugopod (Fig. 4A), while shortly after
at HH30, it was also expressed in the
condensations of the autopod (Fig.
4B). In all cases, the presumptive
joints are excluded from cRor2 expres-
sion.
The initial cartilaginous condensa-
tions of the limb skeleton start to ex-
pand by proliferation and undergo a
series of differentiation steps ulti-
mately resulting in the formation of
hypertrophic cartilage. In a process
called endochondral ossiﬁcation, hy-
pertrophic cartilage is eventually de-
graded and becomes replaced by bone.
The tight regulation of proliferation
on one hand and differentiation on the
other ensures the proper shape and
growth of the skeletal anlagen until
they reach their ﬁnal size. During this
process, expression of cRor2 was ob-
served throughout the area of undif-
ferentiated chondrocytes, but was ex-
cluded from hypertrophic cartilage
(Fig. 4C). Additionally, we performed
section ISH on E15.5 mouse limbs to
compare the expression of cRor2 in
the growth plate to the expression in
the mouse. As in the chick, mRor2 was
expressed strongly in all chondro-
cytes, except hypertrophic cartilage
(Fig. 4D). This ﬁnding was also corrob-
orated by lacZ staining on forelimbs of
Ror2lacZ/ mouse embryos (DeChiara
et al., 2000) (Fig. 4E). Overall, expres-
sion of Ror2 in cartilaginous conden-
sations of the ribs and the limb carti-
lage elements has been found in the
mouse in a pattern equal to what we
observed in the chick (Schwabe et al.,
2004), conﬁrming the evolutionary
conservation of Ror2 expression as we
have observed it in other organs.
Skeletal Defects Caused by
Overexpression of Truncated
Ror2 Variants
Skeletal malformations are a major
ﬁnding in RS (mesomelic limb short-
ening, hemivertebrae) as well as in
BDB (missing phalanges). To gain in-
sight into the functional consequences
of the truncating mutations in both
conditions on limb cartilage develop-
ment, we used the RCAS replication
competent retrovirus. We chose three
different mutations that in humans
lead to either BDB or RS. All muta-
tions truncate the protein within a
range of approximately 60 amino ac-
ids C-terminal of the transmembrane
domain. We generated four different
constructs (Fig. 5A). Two mutations in
chick Ror2 truncated the protein at
positions corresponding to two differ-
ent human BDB mutations (Schwabe
et al., 2000) by introducing a stop
codon. However, human mutations at
these sites result in frameshifts, add-
ing additional amino acids to the
polypeptide until a premature stop is
reached. Thus we made a chimeric
construct carrying the human frame-
shift caused by the 1398insAmutation
(Schwabe et al., 2000) fused to the
chicken Ror2 sequence at the corre-
sponding position (c/hRor2 1374insA).
The fourth mutation (Q494X) trun-
cates the protein at a position identi-
cal to the human RS mutation Q502X
(Afzal et al., 2000). As cloning into the
RCAS virus is limited to a maximal
size of approximately 2.4 kb (Morgan
and Fekete, 1996), the further C-ter-
minal truncations causing BDB and
RS or the full-length wild-type cRor2
could not be used in this system. All
truncated variants of cRor2 in RCAS
are strongly expressed when trans-
fected into chicken DF-1 cells. Pro-
teins were of correct size and were
stable (Fig. 5B).
To analyze the functional conse-
quences of truncating mutations in
Ror2 in vivo and to get an insight into
the function of Ror2 in the chick, we
overexpressed the different mutant
constructs in developing chicken
limbs. RCAS–green ﬂuorescent pro-
tein was used as a control and elicited
no effect on limb patterning and out-
growth (not shown). To assess the
function of mutant Ror2, the trun-
cated constructs were injected into
HH10 forelimb or hindlimb ﬁelds,
which yields high infection through-
out the limb mesenchyme. First, em-
bryos were harvested after a total of 7
days of incubation (HH32). At that
time, the proximal skeletal elements
of the limbs are already established
and start to differentiate, while the
cartilaginous elements of the autopod
are still in the process of condensa-
tion. When the embryos were har-
vested at this early stage, overexpres-
sion of the different constructs
resulted in comparable phenotypes,
thus representative data are shown
for construct E459X only (Fig. 6A).
Overexpression of truncated forms of
Ror2 has no obvious effect on skeletal
patterning, but the cartilage elements
in the wing as well as in the leg ap-
pear shorter and thicker when com-
pared with the uninfected contralat-
eral control limbs. Of interest, the
proximal elements of the zeugopod
and stylopod were more severely af-
fected than the autopod. Humerus
and femur were affected most se-
verely, with the femur showing a re-
duction in size of up to 70%.
Concomitant with the onset of hy-
pertrophic differentiation and ossiﬁ-
cation, functional differences between
the different mutants became appar-
ent. Figure 6B shows representative
examples from injections of the trun-
cated constructs harvested at day 11
of development (HH37; n  8 for
each). Overall, the strongest effects
were observed for the BDB mutations
E459X and 1374insA. In both cases,
the differentiation of the cartilaginous




elements in zeugopod and stylopod
was severely delayed, whereas the au-
topod was only mildly affected. In the
proximal elements, ossiﬁcation was
strongly delayed or completely pre-
vented at HH37, indicating a delay/
block in chondrocyte differentiation.
Infection with the most proximal BDB
truncation (R433X) resulted in a re-
producibly weaker phenotype when
compared with the other BDB mu-
tants and also the RS mutant Q494X.
BDB is a dominant condition. It was
thus speculated that the truncating
mutations causing BDB act as domi-
nant-negatives, whereas RS is most
likely to be caused by loss of protein
function (Schwabe et al., 2000, 2004).
However, in our experimental system,
the RS mutation Q494X causes a phe-
notype comparable to the BDB mu-
tants, albeit weaker than the E459X
and 1374insA mutations.
Of interest, all human mutations
leading to BDB that truncate ROR2
before the TK domain are frameshift
mutations. This ﬁnding raises the pos-
sibility that the presence of an addi-
tional C-terminal peptide might have
an inﬂuence on the pathogenic role of
ROR2. We, therefore, fused the hu-
man frameshift mutation 1398insA
(Schwabe et al., 2000) to the proximal
part of chicken Ror2 at the identical
position (1374; see Fig. 5). As de-
scribed above, overexpression of this
construct showed an identical result
as overexpression of the variant
E459X, which is truncated at the
same position. Most strikingly, a
brachydactyly phenotype was never
observed (Fig. 6B). The smaller size
and the delay in ossiﬁcation observed
in the autopod cartilage elements in-
dicated viral infection in this area,
thus excluding lack of viral spread in
the autopod. In all cases, a mesomelic
shortening of cartilaginous elements
with delay/block of ossiﬁcation was
Fig. 5. Schematic depiction of the different cRor2 mutants used for replication-competent retro-
viral vector–mediated overexpression. A: Constructs were generated corresponding to two differ-
ent Brachydactyly type B (BDB) and one Robinow syndrome (RS) mutation, respectively. Chicken
Ror2 R433X and E459X truncate the protein at positions corresponding to frameshifts/stops set by
the BDB mutations 1321-1325del(5) and 1398insA. A heterologous construct was generated, in
which the human frameshift (FS) caused by the 1398insA mutation was fused to the proximal part
of cRor2, thus exactly copying the BDB mutation (c/hRor2 1374insA, gray box). As a construct
corresponding to a Robinow syndrome mutation (Q502X), a stop mutation was introduced at the
corresponding position 494 in the chick. B: Protein expression from all four viral constructs used
in this study and green ﬂuorescent protein (GFP) -control virus in DF1 cells. As positive control,
protein extract from HEK293 cells transfected with mouse Ror2 full-length was used (right lane).
-actin was used as a loading control.
Fig. 2. Expression of cRor2 in whole chick embryos. Hamburger and Hamilton (HH) stages are indicated. A–D: Whole-mount in situ hybridization (ISH)
showing expression of cRor2 in craniofacial mesenchyme, branchial arches, otic vesicle (arrowheads), dorsal root ganglia (drg, arrows), and
limbs. H,I: Magniﬁcation of forelimbs (FL) and hindlimbs (HL) from stages 23 and 25 are shown. E,F: Vibratome sections from HH25 embryos
hybridized with cRor2 in planes as indicated by dotted lines in B. G: Section ISH showing signal in drg. J: Vibratome section demonstrating cRor2
expression in superﬁcial mesenchymal cell layers in the limb; ectoderm shows no expression (boxed region shown as magniﬁcation below). Ec,
ectoderm.
Fig. 3. Expression of cRor2 mRNA and protein on sections from Hamburger and Hamilton stage (HH) 29 chicken embryos. A–L: In situ hybridizations.
M–S: Immunohistochemistry. A,B: Sagittal and parasagittal sections, respectively, giving an anatomical overview as well as an overview of cRor2
expression. C–J: Magniﬁcation of sections shown in A,B show expression of cRor2 in the heart (C), gizzard and liver (D, arrowhead), rib condensations
(E, arrow), mesonephros (F), spinal chord (G), dorsal root ganglia (H), intestinal loops (I, arrows), and lung (J, arrows). K: cRor2 expression in the head.
L: Magniﬁcation from the boxed area in K. M–S: Immunohistochemistry on cryosections adjacent to those shown in A,B conﬁrms expression of cRor2
in the heart (M), gizzard (N), intestine (O), mesonephros (P), liver (Q), lung (R), and dorsal root ganglia and spinal chord (S). ag, acoustic ganglion; at,
atrium; bp, basilar papilla; cv, cerebral vesicle; cvg, cochleovestibular ganglion; drg, dorsal root ganglia; mc, Meckel’s cartilage; ns, nasal sac; ol, optic
lobe; ov, otic vesicle; ve, ventricle.
Fig. 4. Expression of cRor2 in the developing limb cartilage. A: At Hamburger and Hamilton stage (HH) 27, cRor2 can be detected in the condensations
of the proximal limb cartilage elements. B: At HH30, expression can be seen in the condensations of the phalanges. Presumptive joints are excluded
(arrows). C: In the tibia growth plate at HH35, cRor2 is expressed in undifferentiated, nonhypertrophic chondrocytes and in the perichondrium as
determined by radioactive in situ hybridization. Top: Brightﬁeld picture of section stained with toluidine blue. Bottom: Darkﬁeld image. D,E: A similar
pattern was found in the mouse by in situ hybridization (D) and beta-galactosidase staining on limbs from Ror2lacZ/ embryos (E). Note absence of
beta-galactosidase staining in joint region (arrows). Hc, hypertrophic chondrocytes.
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seen. Thus none of the BDB con-
structs, although the 1374insA vari-
ant was bearing an exact copy of the
human mutation 1398insA, was able
to phenocopy the human phenotype. A
possible explanation might be that the
observed discrepancies are due to spe-
cies differences. In humans, BDB is a
dominant condition characterized by
missing medial and distal phalanges,
but the respective mouse model
(DeChiara et al., 2000) shows a con-
siderably milder phenotype with miss-
ing medial phalanges, which is pene-
trant only in the homozygous
Fig. 6. Consequences of overexpression of different cRor2 mutants in vivo. A: Representative data demonstrating the effect of cRor2-E459X
overexpression in chicken fore- and hindlimbs. Limbs were harvested after 7.5 days of development (Hamburger and Hamilton stage [HH] 32), the limb
skeleton is stained with Alcian blue. Note the shorter and thicker appearance of distal condensations (arrows). B: Comparison of overexpression
phenotypes caused by the different mutations. Limbs were harvested after 11 days (HH37) and stained with Alcian blue and alizarin red. Note the
absence of a brachydactyly phenotype in all cases. C: Hematoxylin and eosin–stained sections through tibia and metatarsal of HH32 injected and
control limbs. Note the lack of ﬂattened chondrocytes in the infected tibia and the disarrayed growth plate in the metatarsal. D: In situ hybridization
with cSox9 and cIhh on tibia sections of HH32 injected and control limbs, demonstrating a block in chondrocyte differentiation. E: Unchanged
proliferation rate (Histone-H3 labeling) on strongly affected HH32 tibia and mildly affected HH37 femur versus contralateral controls. Nuclei are stained
with 4,6-diamidine-2-phenylidole-dihydrochloride (DAPI, blue), Histone-H3 is stained with Alexa Fluor 568 (red). Proliferation rate was assessed as
percentage of Histone-H3–stained nuclei relative to DAPI-stained nuclei within the growth plate. Columns represent mean values from eight different
sections. Error bars represent standard deviations. The differences are insigniﬁcant as determined by Student’s t-test (P  0.2).
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condition. This condition might be one
example where the human limb is
more susceptible to alterations in sig-
naling balances than the mouse or the
chick. Similar ﬁndings have recently
been reported for loss-of-function mu-
tations in Wnt7a, which cause mild
dorsoventral polarity phenotypes in
the mouse (Parr and McMahon, 1995),
but in humans WNT7A loss of func-
tion causes a range of severe limb mal-
formation syndromes (Woods et al.,
2006).
Truncated Forms of Ror2
Delay Chondrocyte
Differentiation
Once initial cartilaginous condensa-
tions are formed, a ﬁne balance of
chondrocyte proliferation and differ-
entiation controls the growth of the
skeletal elements. As shown before,
after overexpression in vivo, the BDB
mutant E459X and 1374insA dis-
played the strongest phenotype. Thus
subsequent experiments were per-
formed with the construct E459X. He-
matoxylin and eosin–stained sections
from infected and control tibia at
HH32 demonstrate presence of small,
rounded chondrocytes throughout the
infected cartilage element, whereas
the control tibia shows the normal
chicken growth plate array of undif-
ferentiated, ﬂattened, and hypertro-
phic chondrocytes (Fig. 6C). In the
metatarsal bones, where the skeletal
preparations had generally shown a
milder phenotype, some degree of
chondrocyte differentiation occurred.
However, the normal growth plate ar-
chitecture was severely disturbed
(Fig. 6C). The undifferentiated ap-
pearance of chondrocytes after overex-
pression of cRor2-E459X was con-
ﬁrmed by in situ hybridization for
cSox9, a marker for early chondro-
cytes. In the wild-type, the diaphysial
region shows no expression of cSox9,
whereas in the infected limb, cSox9
was expressed throughout the carti-
lage (Fig. 6D). Conversely, the wild-
type tibia shows strong expression of
cIhh, a marker for prehypertrophic
chondrocytes (Vortkamp et al., 1996),
which is completely lacking in the in-
fected tibia (Fig. 6D). Again, in the
metatarsals, the delay of differentia-
tion is less pronounced. Expression of
cIhh occurs in infected elements, how-
ever, it is markedly down-regulated
(not shown). Thus truncated Ror2 ap-
pears to severely disrupt growth plate
architecture and chondrocyte differen-
tiation at or before the onset of prehy-
pertrophic differentiation.
To analyze alterations in chondro-
cyte proliferation, we performed phos-
pho-Histone-H3 labeling (Galli et al.,
2004) on sections of infected and con-
trol limbs. We applied this method to
the severely affected tibias infected
with the E459X mutant used above
and also to femurs of less severe af-
fected embryos, which were signiﬁ-
cantly shortened (40%), but still
showed an intact growth plate mor-
phology. As demonstrated in Figure
6E, we did not observe differences in
chondrocyte proliferation in either
case.
Taken together, the overexpression
of truncated forms of cRor2 led to a
severe defect in cartilage differentia-
tion, predominantly in the proximal
elements, without affecting prolifera-
tion. This ﬁnding is in agreement with
previous ﬁndings in the Ror2 null
mouse, where Schwabe et al. (2004)
ascribed the mesomelic limb shorten-
ing to a defect in chondrocyte differen-
tiation but not proliferation. Thus the
effect we observed after overexpres-
sion of BDB mutants mirrors a loss of
function of Ror2, which could be ex-
plained by a dominant-negative action
of the mutant constructs over the en-
dogenous protein. However, the phe-
notype we observed is stronger than in
Ror2/ embryos. This observation in-
dicates that also other pathways may
be negatively inﬂuenced. Of interest,
double knockout of Ror2 and Ror1 in-
creases the phenotypic severity to a
level comparable with our chicken ex-
periments (Nomi et al., 2001), indicat-
ing that mutant Ror2 constructs
might also interfere with Ror1 signal-
ing. In addition, other pathways could
be inﬂuenced by the mutant con-
structs. There is growing evidence
that Ror2 can interact with several of
the Wnt signaling factors (Hikasa et
al., 2002; Oishi et al., 2003; Billiard et
al., 2005). Recently it was shown that
Ror2 can act as a coreceptor for
Wnt5a, thereby leading to inhibition
of canonical Wnt signaling (Mikels
and Nusse, 2006). Moreover, it was
shown previously, that Ror2 can also
interact with and inhibit the bone
morphogenetic protein-receptor type
1b (BmpR1b) pathway, an activity lost
in truncated Ror2-mutants (Sammar
et al., 2004). Interestingly, both Bmp
and Wnt/beta-catenin pathways can
interact on different levels in a variety
of processes (Hoffmann and Gross,
2001, and references therein; Church
and Francis-West, 2002; Grotewold
and Ruther, 2002; Hartmann, 2006).
This might implicate Ror2 at a central
position in a regulatory network inte-
grating distinct pathways by modulat-
ing their activity and potentially also
their cross-talk. It will be a challeng-
ing task to elucidate the relationships
of Ror2 and the different aspects of
canonical and noncanonical Wnt sig-




We derived 222 bp of the 3 coding
sequence and the partial 3 untrans-
lated region (UTR) from chicken EST
369c3 obtained from the BBSRC
(Boardman et al., 2002). Brieﬂy, exon
9 of cRor2 containing the entire ty-
rosine kinase domain was cloned by
genomic walking. Sequence encoded
by exons 2–8 was cloned by PCR from
5-day-old chick embryo cDNA using
degenerate nested 5 primers. The 5
end of the coding sequence and part of
the 5 UTR were determined by 5
RACE (Clontech SMART-RACE kit).
Detailed protocols and primer informa-
tion are available upon request. The
coding sequence of cRor2 has been de-
posited in GenBank EF017720.
In Situ Hybridization and
Immunohistochemistry
For ISH we used two different probes.
A PCR-generated probe (F: TGGTAT-
CAACGCAGAGTACG, R: GGAG-
CACTGCGGCGACAAGC) comprised
a part of the 5 UTR and part of the 5
cds. The PCR fragment was cloned
into pCRII-TOPO (Invitrogen), linear-
ized with HindIII, and transcribed
with T7. A second probe was gener-
ated from pSlax13/cRor2-E459X by
linearization with NcoI and transcrip-
tion with T7. Both probes yielded
identical results. Whole-mount ISH
was carried out as described in
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Schwabe et al. (2004). Section ISH
was carried out as follows: cryosec-
tions were air-dried, ﬁxed in parafor-
maldehyde for 10 min, acetylated for
10 min, and then hybridized overnight
at 70°C. Slides were then washed two
times for 30 min at 65°C with 0.2
standard saline citrate, blocked in
10% goat serum, followed by incuba-
tion with anti–digoxigenin-alkaline
phosphatase (Roche) in 10% goat se-
rum overnight at 4°C. Staining was
performed with nitroblue tetrazolium/
5-bromo-4-chloro-3-indolyl phosphate
(NBT/BCIP; Roche) according to
the manufacturer’s recommendations.
Radioactive 33P-labeled ISH was car-
ried out as in Stricker et al. (2002).
Immunohistochemistry for cRor2
was performed on fresh frozen sec-
tions. After thawing, ﬁxation was
done 10 min with ice-cold methanol at
20°C, followed by washing with
PBS. Permeabilization was done for
10 min with 3% fetal calf serum (FCS)/
0.1% saponin in phosphate buffered
saline (PBS). After washing, sections
were blocked in 10% FCS in PBS over-
night. The next day, the primary an-
tibody (R&D Systems anti-human
ROR2, 1:50) was applied in 5% FCS in
PBS and incubated overnight at 4°C.
After several washing steps, the sec-
tions were incubated with secondary
antibody (anti-goat Alexa Fluor 488,
Molecular Probes, 1:1,000 in 5% FCS/
PBS) and 4,6-diamidine-2-pheny-
lidole-dihydrochloride (DAPI; 1:2,000)
for 1 hr at room temperature. Finally,
after washing in PBS, the sections
were mounted in Fluoromount and
analyzed with a Axiovert-200 ﬂuores-
cence microscope (Zeiss). As a nega-
tive control, secondary antibody was
applied without prior incubation with
anti-ROR2.
Phospho-Histone-H3 labeling was
performed on parafﬁn sections. Sec-
tions were deparafﬁnized, rehydrated,
and boiled for 10 min in 0.01 M so-
dium citrate pH 6.0. Anti-phospho-Hi-
stone-H3 (Upstate) was applied in
0.1% bovine serum albumin in PBS at
1:200 overnight in a humidiﬁed cham-
ber at 4°C. Slides were washed in
PBS, and secondary antibody (anti-
rabbit Alexa Fluor 568, Molecular
Probes) was applied in 10% FCS in
PBS at 1:500 for 1 hr. DAPI (Roche)
was added to this solution at 1:2,000.
After washing in PBS, slides were
mounted in Fluoromount.
Western Blotting
To detect different Ror2 constructs, 20
g of lysate of RCAS-infected DF1
cells or HEK293 cells transfected with
full-length mRor2 were run on a 12%
sodium dodecyl sulphate-polyacryl-
amide gel electrophoresis and blotted
to nylon membrane according to stan-
dard procedures. Ror2 protein was de-
tected with anti-human-ROR2 anti-
body recognizing the extracellular
part of Ror2 (R&D Systems, 1:1,000).
Cloning of cRor2 Constructs,
Virus Production, and
Overexpression
The truncating mutations R433X,
E459X, and Q494X were generated by
PCR on chicken embryo HH27 cDNA







GCAGTACC. The 1374insA fusion
construct was obtained as follows:
ﬁrst, the human frameshift part was




serted A underlined); R, ATGAATT-
CTCATGCCGGAACTCCTCCCGCAG.
Then this PCR product was used as
reverse primer in a fusion PCR on
chicken cDNA together with forward
primer F-Nco (see above). All con-
structs were cloned to pSlax13 by
means of NcoI and EcoRI. Constructs
were shuttled from pSlax13 to
RCAS(BP)A by means of ClaI. Produc-
tion of viral supernatant in DF1 cells
and concentration of viral particles
was performed as described in Morgan
and Fekete (1996). All preparations
used had a viral titer of at least 5 
108 infectious units per milliliter. In-
jection of concentrated virus into
HH10 chick embryo limb ﬁelds was
performed as described in Logan and
Tabin (1998).
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